Big exec payouts, lawsuits mark gene therapy company’s $3.1 billion merger deal For more information please click here to contact Tuan Nguyen By Bizjournals.com Feed (2019-07-12 16:19:27) | December 31, 2019 From Astellas’ initial interest to the close of the deal took six months. But talks turned intense — and another suitor emerged — before the deal was struck Dec. 2. Posted in Sacramento Business Journal